Leading CMO purchases multiple GMP scale twin-column units
Continuous chromatography technology now planned for production suites to give CMO a leading edge with new therapies at attractive cost point. Patented MCSGP will significantly increase yield of oligo and peptide production.
Previous Article
FDA purchases YMC technology Related Posts
April 11, 2025
Shimadzu Visits YMC America
YMC America was pleased to recently host representatives from Shimadzu at our facility in Devens, MA. The visit provided a valuable opportunity for strategic discussion focused on potential cooperative programs between our organizations. Our CEO, Mark Dyment, met with the
April 3, 2025
Strengthening Global Strategy & Collaboration: Insights from Our Executive Trip to Japan
We'd like to share highlights from our executive team's recent trip to Japan! We had a productive week of strategic discussions with our parent company, focusing on the growth and innovation of our consumables and bulk business.
March 20, 2025
St Jude Children’s Research Hospital is Recipient of Employee-Selected Charitable Donation
We're thrilled to announce that YMC America has made a significant donation to St. Jude Children's Research Hospital!
